know about Greater contraceptive education can help manage the impact of Roe vs. Wade
The effects of the SCOTUS Dobbs ruling are being felt throughout the industry.
the overturning of Roe vs. Wade rocked the nation and industry in June; so much so that more than 100 leading women in biotechnology signed an open letter In response to the court’s decision in Dobbsv. Jackson Women’s Health.
The letter expressed the signatories’ disappointment and outrage with the ruling, adding that the Supreme Court ignored the “fundamental rights of women to make personal reproductive health decisions and for physicians to practice evidence-based medicine without fear of reprisal.” “.
Everyone with an interest in reproductive health – hospitals, doctors, patients, and pharmaceutical companies – is trying to determine the most appropriate way to move forward with women’s health care.
“We hope that [the] The decision will have practical impacts on hospitals and health systems, including health care provided across state lines, EMTALA obligations, maternal health care, the doctor-patient relationship, medical education and access. to care for people regardless of socioeconomic status,” said American Hospital Association CEO. Councilor Melinda Hatton said in a June statement, “We are committed to helping our member hospitals and health systems navigate the evolving landscape in accordance with the AHA’s mission to promote the health of all people and communities.
AHA declined to provide additional statements.
Hospitals may find themselves in a precarious situation now that abortion is illegal in some states under certain circumstances. If they follow their previous standards of care policies, they could be breaking the law. If they follow the new law, they could endanger the lives of some patients. Combined with the risk of medical liability, hospitals now have to worry about criminal liability, which is a heavy burden that is imposed on them very quickly.
Heather Woolwine, director of public affairs, media relations and presidential communications at music in South Carolina said that under the new law, the hospital’s focus will remain on the health of mother and baby. “When complications arise during a pregnancy, our providers have a medical and ethical obligation to explain all options to their patients. MUSC and its care providers will continue to provide the most appropriate and safe care possible while adhering to South Carolina Law,” she said.
the Reproductive Health Access Project, which trains, supports and mobilizes primary care physicians to ensure equitable access to sexual and reproductive health care, including abortion, says states where abortion is still legal have seen an “unprecedented increase” in patients who have traveled out of state to seek care. “This surge in demand has put enormous pressure on existing abortion providers,” the group reports. The Project says it is currently working with more doctors and health facilities than ever before to help fill a critical gap in abortion access by providing abortion services in their communities.
“We are already hearing stories from hospitals and clinics that are having trouble determining how to administer appropriate healthcare in light of the restrictions,” said Daré CEO Sabrina Johnson, one of the women who signed the biotech open letter. “As expected, the most affected is the provision of medical care to a pregnant woman, but the Roe vs. Wade The rollback has also affected the provision of care and advice to women seeking highly effective contraceptive methods in light of the rollback.”
Johnson went on to note that doctors have seen an increase in requests from women seeking highly effective birth control methods. Many of these women are in their early reproductive years but request a tubal ligation. In response, doctors and advocacy groups are working to provide enough education for women to understand all of their birth control options, including highly effective reversible methods like implants.
Men also appear to be changing their reproductive health options as more young men seek vasectomies since failure. A Massachusetts urologist reported an increase in men seeking vasectomies in the wake of the court decision, both nationally and locally, in a Worcester Telegram news article Mitchell Sokoloff, MD, professor and chair of the Department of Urology at UMass Chan School of Medicine and UMass Memorial Medical Center, said the increase includes younger men, “who are typically not interested in a so radical about birth control.
Pharma can contribute
According to Terry Weber, CEO of Biote, this is an opportune time for the industry to increase its efforts to educate patients about the efficacy of available contraceptives, long-acting reversible contraceptives, sterilization methods, and the potential benefits for the health they provide to the patient. . It’s also time to focus on helping patients evaluate and find the birth control method that works best for their body.
“Information and education are the best ways to enable patients to feel empowered to seek and be confident in their contraceptive methods,” says Weber.
Debunking myths is a good first step in educating patients. For example, a significant barrier to contraceptive use might be a parent who believes that starting contraception will encourage promiscuity, interfere with future fertility, or cause breast cancer. “These myths need to be vigorously addressed in the media, in schools, and in our doctors’ offices,” says Weber.
“Sharing links, developing stories for the media like we are doing now, handing out educational brochures and pamphlets that talk about common misconceptions, hosting talks in schools are all activities we should be doing to help educate and dispel these myths,” he adds. . .
Various agencies and organizations are trying to generate better contraceptive education for patients and physicians. The United States Department of Health and Human Services released the ReproductiveRights.gov public awareness website, which includes a fact sheet for patients outlining the rights of all patients to reproductive care and access to legally protected insurance coverage. Health insurers must provide coverage for contraceptive services at no cost, as required by the Affordable Care Act.
Johnson de Daré says she believes the pharmaceutical/biotech industry can help ensure women are empowered to control their reproductive rights by ensuring access to accurate information on all currently available contraceptive options, including clear information on correct use and effectiveness.
“In addition, as an industry, we can continue to invest in research and development of new contraceptive technologies to ensure that more options are available to women that better meet their lifestyle goals,” she says. “The best contraceptive for her is the one that you can reliably incorporate into her routine.”